Aller au contenu principal
Profil bibliographique

Gerrit Sijm

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

5Publications signalées
72Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Acute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationRetinoids in leukemia and cellular processesImmune cells in cancerMyeloproliferative Neoplasms: Diagnosis and Treatment

Les publications récentes

Accès ouvert 2025 article OpenAlex

Development of Machine‐Assisted, Human‐Centred Bone Marrow Cell Classification: Feasibility Analysis in Patients With Myelodysplastic Syndromes

Kíyoyuki Ogata, Yuto Mochimaru, Leonie Saft, Gerrit Sijm et autres

Background: Cytomorphological examination and classification of bone marrow (BM) cells using a microscope is essential for diagnosing various diseases affecting the haematopoietic system. However, this requires expertise, is effort-intensive and is inherently subjective. Methods: We developed a method for automatically capturing BM …

us, se, nl, fr, jp (code pays fourni par la source)

2 citations eJHaem
Accès ouvert 2023 article OpenAlex

An Acute Promyelocytic Leukemia Resistant to All-Trans Retinoic Acid: A Case Report of the ZBTB16::RARa Variant and Review of the Literature

Daan A R Castelijn, Gerrit Sijm, Bianca Venniker‐Punt, Pino J. Poddighe et autres

Introduction: Acute promyelocytic leukemia (APL) is characterized by the PML::RARa gene fusion and treatment consists of all-trans retinoic acid (ATRA). Rarely, genetic APL variants have been described which are insensitive to ATRA treatment and are therefore associated with a worse prognosis. Rapid …

nl (code pays fourni par la source)

5 citations Case Reports in Oncology
Accès ouvert 2023 supplementary-materials OpenAlex

Supplementary Material for: An acute promyelocytic leukemia resistant to all-trans retinoic acid: a case report of the ZBTB16::RARa variant and review of the literature

Castelijn D.A.R., Gerrit Sijm, Bianca Venniker‐Punt, Poddighe P.J. et autres

Introduction Acute promyelocytic leukemia (APL) is characterized by the PML::RARa gene fusion and treatment consists of all-trans retinoic acid (ATRA). Rarely, genetic APL variants have been described which are insensitive to ATRA treatment and are therefore associated with a worse prognosis. Rapid …

0 citations Figshare
Accès ouvert 2018 article OpenAlex

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Jacqueline Cloos, Jeffrey R. Harris, Jeroen J. W. M. Janssen, Angèle Kelder et autres

Response criteria in acute myeloid leukemia (AML) has recently been re-established, with morphologic examination utilized to determine whether patients have achieved complete remission (CR). Approximately half of the adult patients who entered CR will relapse within 12 months due to the outgrowth …

us, nl, be (code pays fourni par la source)

38 citations Journal of Visualized Experiments
Accès ouvert 2018 article OpenAlex

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Jacqueline Cloos, Jeffrey R. Harris, Jeroen J. W. M. Janssen, Angèle Kelder et autres

Response criteria in acute myeloid leukemia (AML) has recently been re-established, with morphologic examination utilized to determine whether patients have achieved complete remission (CR). Approximately half of the adult patients who entered CR will relapse within 12 months due to the outgrowth …

us, nl, be (code pays fourni par la source)

27 citations Journal of Visualized Experiments

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.